Plasma levels of sRANKL and OPG are associated with atherogenic cytokines in patients with intermediate cardiovascular risk.

about

Plasma levels of sRANKL and OPG are associated with atherogenic cytokines in patients with intermediate cardiovascular risk.

Item

http://www.wikidata.org/entity/Q36388215

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Plasma levels of sRANKL and OP ...... ermediate cardiovascular risk.

@ast

Plasma levels of sRANKL and OP ...... ermediate cardiovascular risk.

@en

type

Item

label

Plasma levels of sRANKL and OP ...... ermediate cardiovascular risk.

@ast

Plasma levels of sRANKL and OP ...... ermediate cardiovascular risk.

@en

prefLabel

Plasma levels of sRANKL and OP ...... ermediate cardiovascular risk.

@ast

Plasma levels of sRANKL and OP ...... ermediate cardiovascular risk.

@en

P1476

Plasma levels of sRANKL and OP ...... ermediate cardiovascular risk.

@en

P2093

Barbara Dietel

http://www.w3.org/2001/XMLSchema#string

Christian Schlundt

http://www.w3.org/2001/XMLSchema#string

Christian Stumpf

http://www.w3.org/2001/XMLSchema#string

Christoph D Garlichs

http://www.w3.org/2001/XMLSchema#string

Dorette Raaz-Schrauder

http://www.w3.org/2001/XMLSchema#string

Lutz Klinghammer

http://www.w3.org/2001/XMLSchema#string

Michael G Schrauder

http://www.w3.org/2001/XMLSchema#string

Piotr Lewczuk

http://www.w3.org/2001/XMLSchema#string

Tobias Kilian

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity

Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells.

Associations of inflammatory markers with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis

P2888

s00380-017-0998-z

P31

scholarly article

P356

10.1007/S00380-017-0998-Z

http://www.w3.org/2001/XMLSchema#string

P50

Stephan Achenbach

P577

2017-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28567553

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis